Cocrystal Pharma Inc (COCP)
Cocrystal Pharma is a biotechnology company engaged in discovering and developing antiviral therapeutics as treatments for serious and/or chronic viral diseases. Co. is developing antiviral therapeutics that inhibit the viral replication function of RNA viruses causing acute and chronic viral diseases. Co.'s targets include treating influenza virus, coronavirus and norovirus infections by discovering and developing drug candidates targeting the viral replication process. Additionally, Co. is targeting to decrease the duration of Hepatitis C virus (HCV) therapy by developing its drug candidate targeting HCV RNA-dependent RNA polymerase enzyme through partnerships and/or licensing activities.
| Company Name: |
Cocrystal Pharma Inc |
| Website: |
www.cocrystalpharma.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding COCP: |
2 |
| Total Market Value Held by ETFs: |
$410162 |
| Total Market Capitalization: |
$16.00M |
| % of Market Cap. Held by ETFs: |
2.56% |
|
|
April 26, 2024 • 8:50 PM Eastern
Strong Buy (4.00 out of 4)
95th percentile
|
|
Free COCP Email Alerts:
